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Abstract
Background: Assessing people's ability to drive has become a public health concern in most
industrialized countries. Although age itself is not a predictive factor of an increased risk for
dangerous driving, the prevalence of medical conditions that may impair driving increases with age.
Because the implementation of a screening for unsafe driving due to medical conditions is a public
health issue, its usefulness should be judged using standardised criteria already proposed for
screening for chronic disease. The aim of this paper is to propose standardised criteria suitable to
assess the scientific validity of screening for unsafe driving due to medical conditions, and identify
potential issues to be clarified before screening can be implemented and effective.
Discussion: Using criteria developed for screening for chronic diseases and published studies on
driving with medical conditions, we specify six criteria to judge the opportunity of screening for
unsafe driving due to medical conditions. This adaptation was needed because of the complexity of
the natural history of medical conditions and their potential consequences on driving and road
safety. We then illustrate that published studies pleading for or against screening for unsafe driving
due to medical conditions fail to provide the needed documentation. Individual criteria were
mentioned in 3 to 72% of 36 papers pleading for or against screening. Quantitative estimates of
relevant indicators were provided in at most 42% of papers, and some data, such as the definition
of an appropriate unsafe driving period were never provided.
Summary: The standardised framework described in this paper provides a template for assessing
the effectiveness (or lack of effectiveness) of proposed measures for screening for unsafe driving
due to medical conditions. Even if most criteria were mentioned in the published literature pleading
for or against such a screening, the failure to find quantitative and evidence-based estimates of
relevant indicators provides useful insight for further research.
Background
Road safety has become a major public health concern in
European countries, as elsewhere in the developed world
[1]. Prevention programmes are most often targeted at the
two age groups the most at risk of collision-related inju-
ries, the young and the older drivers [2,3]. Young drivers
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are at higher risk of collision because of their risky driving
behaviours, whereas older drivers seem to be at higher risk
of collisions because of functional impairments [4-7]. In
a recent study from the United States [8], drivers aged 15
to 24 years had the highest nonfatal injury rate (1934 per
100 million person-trips), followed by those aged 25 to
64 years; drivers older than 65 years had the lowest non-
fatal injury rate (600 per 100 million person-trips) but a
higher fatal injury rate than middle-aged drivers (15 ver-
sus 8 per 100 million person-trips). The apparent over-
representation of older drivers in fatal collisions is related
to their greater physical frailty and vulnerability to injury
when involved in a collision [8]. Although age itself is not
a predictive factor of an increased risk for dangerous driv-
ing, the prevalence of medical conditions that may impair
driving ability increases with age.
To deal with adverse consequences of driving with medi-
cal conditions, countries, states or provinces have adopted
contrasting policies, including standard periodic renewals
of the driving license [9,10], age-based license renewal
procedures [6], or, as is the case in France, no policy [1].
These procedures are often simple administrative renewal
of the license; in other places applicants must perform
tests such as vision tests, or even road tests when specific
medical conditions are present [11-13]. Drivers who fail
the tests may have their driving privileges revoked, or driv-
ing restrictions. However, these official guidelines are
often based on expert opinions rather than on docu-
mented and critically assessed evidence [14-16].
Because the implementation of screening for unsafe driv-
ing due to medical conditions is a public health issue, its
usefulness should be judged using guidelines and stand-
ardised criteria already proposed for screening for chronic
diseases [17]. As in usual screening programmes, indeed,
it is important to balance potential positive and negative
effects. Moreover, as driving is an essential component of
daily living and a major skill potentially needed for inde-
pendence in everyday adult life, screening measures may
have unwanted harmful consequences [1,18,19].
The aim of this paper is to propose standardised criteria
suitable to assess the scientific validity of screening for
unsafe driving due to medical conditions, and identify
potential issues to be clarified before screening can be
implemented and effective. Even if the literature is mainly
targeted at older drivers, we provide a generalized frame-
work to judge the indication of screening for any medical
conditions, age groups, strategies, and types of interven-
tions. We also illustrate the need for such a standard
through a survey of published studies pleading for or
against screening for unsafe driving, that fail to provide
appropriate data.
Discussion
Using existing criteria developed by Wilson and Jungner
in 1968 for screening for chronic diseases [20], then
adapted in different fields such as cancer [21], blood
transfusion [22], or psychotic disorders [23], and pub-
lished studies dealing with driving with medical condi-
tions, we specified a general framework providing six
criteria to judge the opportunity of screening for unsafe
driving due to medical conditions. These criteria are trans-
lated into six key questions and related public health indi-
cators.
Criteria for the indication of screening for unsafe driving
Are the consequences of the medical condition on road safety severe 
enough to move from an individual medical decision making to a 
systematic screening programme?
To justify a screening programme, there should be: 1/ a
high frequency of the medical condition possibly associ-
ated with unsafe driving, i.e. a high prevalence in the gen-
eral population; 2/ a high proportion of individuals with
the medical condition who are current drivers; 3/ a high
proportion of drivers with the medical condition who
really become unsafe drivers; and 4/ a documented higher
risk of collision in those drivers who are unsafe because of
the medical condition. Estimation of these indicators is
difficult as they are strongly related to self-regulation strat-
egies potentially adopted by impaired road users (Figure
1). Some individuals, aware of their diminishing driving
abilities, may stop driving, thus do not represent a road
safety problem anymore [24]. Other self-regulation strat-
egies involve driving behaviours that allow drivers to
remain safe, despite the medical condition [25,26]. For
instance, drivers may avoid challenging and at-risk situa-
tions (such as left turns) and thus will not be at higher risk
of collision [27]. It is thus important to take into account
these potential strategies when assessing the actual sever-
ity of the consequences of medical conditions on road
safety.
Is the potentially unsafe driving period long enough to be detected 
and to implement an effective early intervention?
To implement an early intervention, whatever the context,
one must be able to identify a period during which the
inability to drive can be detected, and an intervention
could be effective. This period, referred to in other con-
texts as the preclinical phase [17], could be called here the
"unsafe driving" period. The unsafe driving period starts
when the actual driving performances of the individual
become systematically lower, because of the medical con-
dition, than the performances needed to drive safely (Fig-
ures 2a and 2b). This period must be long enough to allow
early detection of unsafe driving, and implement an early
effective intervention, before the lower performances
actually result in a collision.BMC Public Health 2008, 8:27 http://www.biomedcentral.com/1471-2458/8/27
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The definition of the unsafe driving period could be based
on models of driver behaviour [28] such as the task-capa-
bility interface model [29], which takes into account the
interaction between task demand and capability. The
problem is that many corresponding parameters are
unknown. Firstly, we do not know, for most medical con-
ditions, the shape of the evolution of the performances of
the driver (capability) [30]. This shape is likely to depend
on the natural history of the medical condition, the initial
ability of the driver (i.e. driving skills, as influenced for
instance by experience), and the driving behaviour (self-
regulation strategies to avoid difficult or at-risk situa-
tions). Secondly, the shape of the evolution of perform-
ances needed to drive safely (task demand) is also
unknown as these needs are sensitive to environmental
factors, risk exposure, the initial ability of the driver, and
his/her driving behaviour. As illustrated in Figure 2a, a
driver with a medical condition (or any driver as a matter
of fact) could be at higher risk of collision due to an acute
increase of the task demand because of environmental fac-
tors, or an acute decrease of the capability of the driver,
independently of the medical condition. For instance,
hearing the bad news can detract from driver competence
to yield a somewhat lower level of capability [31].
Another sensible hypothesis is that the driver compen-
sates the risk of collision related to the medical condition
by adopting self-regulation strategies and thus decreasing
the task demand. This can theoretically postpone (Figure
2b), or completely avoid the entry into the unsafe driving
period (Figure 2c). These uncertainties highlight the diffi-
culty to define the starting point of the unsafe driving
period, and, consequently, the threshold below which
observed performances are actually dangerous, and the
appropriate interval between two screens.
Is there a reliable and valid test to detect unsafe driving and predict 
the risk of collision?
A screening programme can be considered only if there is
a reliable and valid test during the potential unsafe driving
period. The reliability and the validity of the tests are
defined as for screening for chronic disease, i.e. respec-
tively by the inter- and intra-observer reproducibility of
the test and the sensitivity and specificity in the unsafe
driving period. Moreover, the screening test should be
easy to administer, brief and cost-effective.
The main difficulty in applying this criterion is the exist-
ence of three levels of performances of the test potentially
Natural history and impact of a medical condition on road safety, with and without screening Figure 1
Natural history and impact of a medical condition on road safety, with and without screening. Is1 to Is4 are indica-
tors of severity, Fms is a potential modifier of the indicators of severity; Ipe1 and Ipe2 are indicators of potential expected pos-
itive effects of the early intervention; Ine1 to Ine5 are indicators of potential expected negative effects of the early intervention; 
Ip1 to Ip3 are indicators of performance of screening tools required to detect unsafe driving (see text for details).BMC Public Health 2008, 8:27 http://www.biomedcentral.com/1471-2458/8/27
Page 4 of 10
(page number not for citation purposes)
considered (noted Ip1 to Ip3 in Figure 1). The need for
valid and reliable screening tools applies to: 1/the diagno-
sis of the medical condition; 2/the detection of unsafe
behaviours due to this medical condition; and 3/the pre-
diction of the actual risk of collision of a driver diagnosed
unsafe. Availability of screening tools for the diagnosis of
the medical condition is not the major issue here, as such
tests are usually available, for instance for clinical pur-
poses.
The main issue lies in the availability of tools to detect
unsafe driving due to the medical condition and to predict
the real-condition risk of collision of the driver considered
unsafe. In other terms, detection of the medical condition
or of so-called unsafe behaviours is only acceptable if
these behaviours have been demonstrated to be good
proxy markers of the actual risk of collision and its severe
consequences [19]. Indeed, the aim of the screening test is
not only to distinguish drivers who pass or fail the test but
to detect drivers who are really at risk of severe collisions.
For instance, when assessing driving ability of older driv-
Hypothetical illustrations of the definition of the potential unsafe driving period Figure 2
Hypothetical illustrations of the definition of the potential unsafe driving period. Dark line is the evolution of the 
observed performances of the driver; light line is the evolution of the performances needed to drive safely; actual shapes are 
unknown and hypothetical. a) possible typical situation: the increased risk of collision is due to an acute increase of the per-
formances needed to drive safely (point 1), to an acute decrease of actual performances of the driver (point 2), or because the 
driving performances of the driver with a medical condition become systematically lower than the performances needed to 
drive safely (unknown position of point 3). b) the self-regulatory strategies delay the entry in the potential unsafe driving period 
(shift of point 3). c) the self-regulatory strategies avoid the entry in the potential unsafe driving period.BMC Public Health 2008, 8:27 http://www.biomedcentral.com/1471-2458/8/27
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ers with dementia, there is no test today that is both appli-
cable and clearly and strongly associated with future
collisions [19]. For instance, on-road assessment is con-
sidered as the "gold standard" evaluation of driving com-
petence for driver with dementia, but it is expensive,
based on subjective criteria, and not standardised [19].
Another key issue is whether the best context to assess the
ability to drive is the general population of all drivers (sys-
tematic screening), or medical contacts for other reasons
(case-finding). A recent study of the association between a
medical contact and the risk of road-vehicle collisions in
older drivers from Quebec indicated that a recent medical
contact is associated with an increased risk of crash, thus
could represent an opportunity to detect drivers poten-
tially at risk [32].
What should be the early intervention for drivers diagnosed unsafe?
The first step is to choose the type of early intervention to
impose on drivers diagnosed unsafe. Early interventions
most often proposed in the literature range from educa-
tional or training programmes to promote safe mobility
[33,34] to driving restrictions (geographic areas, hours,
type of roads...), including driving cessation [10,35,36].
The latter would be the most logical intervention if the
only criterion for judging effectiveness were the impact on
the risk of collision. However, the effectiveness of an early
intervention is the level to which this intervention meets
this objective (number of collisions avoided, possibility
to keep driving, and thus to assure mobility), taking into
account potential negative effects of this intervention.
Indicators of potential positive effects (Ipe1 and Ipe2 in
Figure 1) of an early intervention such as driving cessation
could be the number of saved lives or the reduction of the
risk of severe injuries since the intervention has been
implemented [10,35,36], or, if the intervention is an edu-
cational programme, the increase in self-awareness and
self-regulatory processes [33,34]. On the other hand,
potential negative effects of the intervention (Ine1 to Ine5
in Figure 1), related to an inappropriate and premature
cessation of driving, could be a loss of autonomy or
mobility, depression, and the difficulty to access to alter-
native modes of transportation [19]. Therefore, the main
difficulty is to choose the type of intervention to imple-
ment according to the published evidence on its potential
effectiveness.
Would the proposed screening programme result in more good than 
harm?
Beyond the effect of the intervention in drivers diagnosed
unsafe, evaluation of the screening programme should
also consider the effect of the programme for all the tar-
geted population, including drivers who are not unsafe.
The acceptability of both the considered early interven-
tion (discussed above in the 4th criterion) and of the
screening procedures for all drivers targeted should be
assessed. Safe and simple screening procedures would be
better accepted. For instance, it is unclear whether an
assessment of driving abilities using a driving simulator
would be better accepted than an on-road driving test.
Good validity and reliability of screening tests are also of
major importance in the acceptability of the programme,
as it is important to minimize the false negatives (falsely
reassuring) and false positives (falsely labelling and
penalizing). Minimizing the number of false positives is
even more important, given that the risk of collision
(mostly an issue in truly unsafe drivers) is likely to be
lower than the risk of potential adverse consequences (an
issue for all positive drivers). These negative consequences
(loss of autonomy, need to use other modes of transpor-
tation, depression...) would be even less acceptable for
drivers wrongly diagnosed unsafe.
Would the minimal resources required to implement an effective 
screening programme be acceptable to the society?
Implementation of an effective and safe screening pro-
gramme can only be considered if the increase in
resources needed to reach the objectives is acceptable to
the decision maker and the society. It should consider: 1)
the minimal resources requirements needed to maximize
the positive effects and minimize the negative effects,
including administrative and technical resources (diagno-
sis of unsafe driving, implementation and follow-up of
the early intervention) and human resources (health pro-
fessionals involved in the process); 2) the costs of imple-
menting all these elements of the screening programme;
and 3) whether the expected effects justify the costs using
for instance decision analysis methods. Indeed, routine
screening with diagnostic tests lacking validity will be
costly, as this would target many drivers for further evalu-
ations, such as on-road tests, and would overwhelm exist-
ing resources.
Critical analysis of published articles pleading for or 
against screening
Search and study sampling
Studies potentially eligible were to be published articles in
peer-reviewed journals, and to explicitly plead for or
against a screening programme to detect unsafe driving
due to medical conditions. This information could be
provided in the title, the objective, the abstract or the dis-
cussion of the article. Potentially eligible studies have
been assessed against the inclusion criteria by one
reviewer (SL) and, if any doubt, by a second reviewer
(LRS).
Electronic searches have been undertaken using
MEDLINE, EMBASE, PASCAL and FRANCIS databases to
search articles published from January 1985 to December
2006 (Table 1). We considered original studies, editorialsBMC Public Health 2008, 8:27 http://www.biomedcentral.com/1471-2458/8/27
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or reviews published in English, Spanish or French. We
also updated the search using the Safetylit website
[37]which provides an updated literature on injury pre-
vention and safety promotion with a special section
"transportation issues".
The selected studies were then assessed using a standard
form listing the criteria for the usefulness of screening for
unsafe driving due to medical conditions (Table 2). We
counted how many of these studies pleading for or against
such a screening programme had mentioned the criteria
and how many studies provided relevant quantitative esti-
mates to document these criteria.
How criteria are met in published studies pleading for or against 
screening
Electronic searches and updates yielded 225 potentially
eligible studies. Only 62 papers were articles published in
peer-reviewed journals, and related to the issue of unsafe
driving due to medical conditions. Of these 62 papers, 36
explicitly pleaded for (18 papers) or against screening (18
papers) and were included in the analysis [2,3,5-
7,9,10,19,27,30,33-36,38-59]. Almost all studies dealt
with screening of cognitive impairments in older drivers.
The percentage of papers mentioning relevant criteria
ranged from 3% to 70% (Table 2).
Consequences of medical conditions on road safety are poorly 
documented
A majority of papers (70%) mentioned this criterion, and
documented both the prevalence of the medical condition
and the proportion of individuals with the medical condi-
tion who drive, but failed to document the frequency of
self-regulation strategies and the impact on road safety.
Three studies pleading for screening indicated that the
prevalence of dementia ranged from 2 to 8% for people
aged 65 years and over, and 80% for 80 years and over
[7,19,45]. One study pleading for the usefulness of screen-
ing for driver sleepiness indicated that the prevalence of
obstructive sleep apnoea (OSA) ranged from 2% to 8%
[51].
Table 2: Criteria used in 36 published papers pleading for or against screening for unsafe driving. 36 published papers include 29 
original studies, 4 literature reviews and 3 editorials; documented means that quantitative estimates were provided, indicators in 
parentheses are defined in figure 1
Criteria and corresponding indicators Mentioned Documented
n% n %
1. Are the consequences of the medical condition on road safety severe enough? 25 70 14 39
High prevalence of the medical condition (Is1) 15 42 3 11
High proportion of individuals with medical condition who drive (Is2) 10 28 4 11
High proportion of drivers with medical condition who become unsafe (Is3) 00 0 0
Higher risk of collision of unsafe drivers due to medical condition (Is4) 21 58 6 17
Frequency of potential self-regulation strategies (Fms) 12 33 3 8
2. Is the potentially unsafe driving period defined and long enough? 1 3 0 0
Definition of a potential unsafe driving period 0 0 0 0
Length of the unsafe driving period 1 3 0 0
3. Is there a reliable and valid test? 24 67 13 36
Performance of diagnostic test to detect medical conditions (Ip1) 51 4 1 3
Performance of diagnostic test to detect unsafe driving (Ip2) 18 50 12 33
Prediction of collision risk (Ip3) 14 39 6 17
4. What should be the early intervention for drivers diagnosed unsafe? 20 55 15 42
Nature of intervention 13 36 7 19
Expected positive effects (Ipe) 11 30 7 19
Expected negative effects (Ine) 12 33 2 5
5. Would the proposed screening programme result in more good than harm? 19 53 2 5
6. Would the minimal resources required to implement the screening programme 
acceptable?
82 2 2 5
Table 1: Search terms used to identify potentially eligible 
articles
Database Search terms
MEDLINE "accidents, traffic/prevention and control"
AND "automobile driver examination"
or
"accidents, traffic/prevention and control"
AND "automobile driving" AND "screening"
or
"accidents, traffic/prevention and control"
AND "automobile driving" AND "mass screening"
EMBASE "automobile driving" AND "screening"
FRANCIS/
PASCAL
"vehicle driving" AND "performance evaluation"
or
"vehicle driving" AND "medical screening"BMC Public Health 2008, 8:27 http://www.biomedcentral.com/1471-2458/8/27
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Two studies pleading for screening documented that
almost 30% of patients with dementia are active drivers
for approximately 4 years following the diagnosis [19,45].
Only three studies (all pleading for screening) provided
information on potential self-regulation strategies
[27,38,47] and showed an effect of age on all driving hab-
its: drivers aged 75 and over drive less often at night, and
avoid difficult situations [27]. However there was no evi-
dence that these changes in driving habits were related to
a lower collision rate [27]. From 22 to 50% of patients
with Alzheimer disease stopped driving because of their
cognitive problems [38,47]. The proportion of drivers
with a medical condition, who were still driving was often
mentioned by the authors, but quantitative estimates were
lacking. Arguments on self-regulation strategies of older
drivers with medical conditions were most often reflecting
the opinion of the authors rather than scientific evidence.
No paper distinguished drivers with medical conditions
who are still safe drivers from those who really have
become unsafe. Quantitative estimates of the risk of colli-
sion of drivers with medical conditions were rarely pro-
vided: one study pleading for screening of drivers with
dementia estimated that the relative risk (RR) of collision
was between 2 and 5 compared to non-demented drivers
[45]; for young drivers with attention-deficit/hyperactivity
disorder (ADHD), one study pleading against screening
reported an RR of 1.54 [46]; finally, for male drivers with
OSA and aged 36 to 60 years (whose screening was judged
indicated by Pierce et al), the reported RR was 3 [51]. For
other conditions, no evidence was reported on the rela-
tion between these medical conditions and a proven
higher risk of collisions.
The definition of a potential unsafe driving period is never mentioned 
nor documented
This was the most important limitation of published stud-
ies pleading for or against screening, for any kind of med-
ical condition.
The performance of potential screening tools to detect unsafe drivers 
and predict the risk of collision are poorly documented
The performance of potential screening tools was men-
tioned in 50% of the papers, but studies failed to docu-
ment the validity of these tests to detect driving
competency and predict the risk of collision. Two studies
pleading for screening of older drivers with dementia
indicated that the Useful Field Of View (UFOV) was the
best developed screening measure for visual attention
[19,33]. Dobbs et al also indicated that the Mini Mental
State Examination (MMSE) is of questionable utility for
predicting driving competence and suggested that the
Clinical Dementia Rating (CDR) could be used to assess
driving competence [19]. Another study pleading for
screening of older drivers with dementia concurred [38].
Finally, Ducheck et al. [39], also pleading for screening,
along with Dobbs et al. [19], considered that on-road
assessment was the "gold-standard" evaluation to assess
driving ability but had several limits. Screening tests pro-
posed by the authors were often screening tools devel-
oped to detect the medical condition but with no proven
validity to detect driving competency. This is related to the
lack of insight in the distinction between the medical con-
dition and the inability to drive.
The prediction of collision risk was considered in almost
40% of the papers but poorly documented. Two studies,
one pleading for and one against screening, found that
poor performance on neuropsychological tests assessing
cognitive abilities is related to future collisions (RR rang-
ing from 1.5 to 3) [56,57], whereas another study, also
pleading for screening, claimed that these tests were not
sufficiently correlated with future collisions to be valid
predictors [19]. One study pleading for screening for vis-
ual impairment highlighted that older drivers with a 40%
or greater impairment in the UFOV were 2.2 times more
likely to be involved in a collision during the 3 years of
follow-up [50]. The main weakness of the studies plead-
ing for one test or another was that the predictive value
was most often estimated from the correlation with per-
formance on an on-road test or a simulator, without doc-
umentation that these results were correlated with driving
ability in real condition.
The effectiveness of potential early interventions for drivers 
diagnosed unsafe is poorly documented
Characteristics of the considered early intervention were
mentioned in 55% of the studies. Both potential positive
and negative effects of the intervention were mentioned in
two-thirds of the papers. However, these potential posi-
tive effects were poorly documented and quantitative esti-
mates of the incidence of unwanted consequences were
scarce.
The best evidence of potential expected positive effects,
provided by two studies pleading for screening of older
drivers with dementia, was that: 1) an educational inter-
vention could promote self-awareness and self-regulatory
processes [33], and 2) restricted licenses to less demand-
ing situations would allow the demented driver with lim-
ited competences to drive safely [19]. Another study
(against screening) provided quantitative data on the
expected positive effect of in-person license renewal,
showing that this intervention was associated with a lower
fatality rate (RR = 0.83); however vision and road tests
were not associated with additional benefits [10]. In the
study of Marshall et al. [35], pleading for restricted poli-
cies for medical impairments, restricted licensing
appeared to decrease rates of traffic violations (RR = 0.93),
and collision rates (-12%). In another study pleading forBMC Public Health 2008, 8:27 http://www.biomedcentral.com/1471-2458/8/27
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screening, vision policies targeted at drivers 60 years and
over were significantly associated with lower fatality rates,
with a 12% decrease over a 3-year period [36]. In 2004,
Owsley et al. [34] found that an educational programme
for visual impairment did not enhance driver safety, mod-
erating the indication of such a screening.
Only two studies provided data on the potential negative
effects of the intervention. Dobbs et al. [19], although
pleading for screening, argued that using a "co-pilot" is
not effective since the driver needs attention both on the
road and on the "co-pilot" and thus performs less well;
they also argued that driving cessation can be difficult for
many patients with dementia and their caregivers who
have to deal with the loss of mobility. Finally, in one study
pleading against screening, mandatory testing was associ-
ated with a higher risk of collision compared to no testing
(RR = 1.15) [9].
The balance between benefits and risks of the screening programme 
is almost never documented
The acceptability of the programme was mentioned in
53% of the papers. The study of Hakamies et al. [43] eval-
uated the potential safety effect of age-related medical
screening in Finland, compared to Sweden where no med-
ical screening exists. They demonstrated that age-related
variation of vehicle collision and fatality trends was simi-
lar in both countries, suggesting that there was no safety-
related reason to implement age-based medical screening
for older drivers. Moreover, many disadvantages and risks
are associated with age-based screening, such as the trans-
fer to riskier travel modes [39] or the induced premature
cessation of driving and subsequent immobility [40].
The poor feasibility of screening is well documented by two cost-
effectiveness analyses
The feasibility and efficiency of the screening programme
was only mentioned in 20% of the papers. Two published
analyses showed that expected benefits of a screening tar-
geted to older drivers with cognitive impairment are very
limited compared to expected costs. In the cost-benefit
analysis of Retchin et al. [52], screening for dementia in
older drivers every 5 years was associated with a benefit
lower than one day of life gain. In the analysis of Via-
monte et al. [59], a mass intervention targeted to all older
drivers was more cost-effective than a screening pro-
gramme. None of these analyses considered side effects of
screening.
Summary
The standardised framework described in this paper pro-
vides a template for assessing the effectiveness (or lack of
effectiveness) of proposed measures for screening for
unsafe driving due to medical conditions. Indeed, even if
most of the defined criteria were mentioned in the pub-
lished literature, there is a lack of quantitative and evi-
dence-based estimates of relevant indicators that
essentially exist for older drivers with cognitive impair-
ment. Although many official guidelines and recommen-
dations provide, for example in France, a list of medical
conditions potentially incompatible with driving (for
instance psychotic disorders, excessive sleepiness, severe
and permanent cardiac insufficiency...), there is no data,
in published studies pleading for or against screening,
allowing to judge the need for screening for unsafe driving
due to these medical conditions.
Identification of potential issues provides useful insight
for further research. Importantly, we need more data on
self-regulation strategies potentially adopted by drivers
with medical conditions to accurately estimate their real
impact on driving exposure and the risk of collision.
Although there is evidence that some medical conditions
(sleep apnoea, visual impairment, dementia, epilepsy or
diabetes) are statistically associated with a higher risk of
collision, these associations are usually not clinically
meaningful. Most studies considered that having the med-
ical condition (whatever the severity) implied unsafe driv-
ing. It is actually difficult to distinguish drivers with the
medical condition who become at a clinically higher risk
of collision [60-62]. We also dramatically need to docu-
ment the unsafe driving period. Finally, there is no con-
sensus today on a valid and reliable screening tool to
detect unsafe driving and predict the risk of collision in
real conditions, and on an early effective intervention,
accepted by unsafe drivers and the society. A cohort study
would be the best design to get the information needed.
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